Articles From: Sarepta Therapeutics Announces Regulatory Update on Eteplirsen to Ashford Trust Announces Corporate Governance Enhancements


Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today provided an update on its discussions with the U.S. Food and Drug Administration (FDA) regarding its planned New Drug Application (NDA) submission for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD). In meeting minutes received last week from a Type B Pre-NDA meeting that took place in September 2014, the FDA provided updated guidance regarding the specific data to be included as part of, or at the time of, Sarepta’s NDA submission.
Sign-up for Sarepta Therapeutics Announces Regulatory Update on Eteplirsen investment picks
Agenus Inc. (NASDAQ: AGEN) will report its third quarter 2014 financial results before the market opens on Friday, October 31, 2014.
Sign-up for Agenus to Report Third Quarter 2014 Financial Results on October 31, 2014; Conference Call to Follow investment picks
http://media.marketwire.com/attachments/201211/102974_EvolvinglogoR.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153883&ProfileId=051205&sourceType=1 ENGLEWOOD, CO --
Sign-up for Evolving Systems Sets Date for 2014 Third Quarter Results News Release and Conference Call investment picks
UCP, Inc. (NYSE:UCP) today announced that it will release its financial results for the third quarter ending September 30, 2014 before the market opens on Monday, November 10, 2014, and will subsequently host a conference call for investors and other interested parties beginning at 12:00 p.m. Eastern Time, 9:00 a.m. Pacific Time.
Sign-up for UCP to Host Third Quarter 2014 Earnings Conference Call investment picks
BATON ROUGE, La., Oct.
Sign-up for Investar Holding Corporation Announces 2014 Third Quarter Results investment picks
Data from Sublingual Sufentanil Development Program Highlights Analgesic Response Compared to IV Morphine in Young vs Elderly Adult Patients REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting investment picks
GAAP Diluted Earnings Per Share (DEPS) $1.54; Adjusted DEPS $1.55 Operating Cash Flow of $226 million, 25.6% of Revenue Full Year Guidance Increased SARASOTA, Fla.
Sign-up for Roper Industries Announces Record Third Quarter Results investment picks
Valeant Delivers Letter To Allergan Board Canada NewsWire · Prepared to Improve Offer And Provide Value of at Least $200 a Share · Urges Allergan Board to Take Control of Process LAVAL, Quebec , Oct.
Sign-up for Valeant Delivers Letter To Allergan Board investment picks
· Prepared to Improve Offer And Provide Value of at Least $200 a Share · Urges Allergan Board to Take Control of Process LAVAL, Quebec , Oct.
Sign-up for Valeant Delivers Letter To Allergan Board investment picks
2014/10/27
Italian market watchdog Consob on Monday imposed a temporary short-selling ban on shares of Banca Monte dei Paschi di Siena Spa (IT:BMPS) as they sank 20% on the Milan stock exchange.
Sign-up for Italy bans short selling on Monte dei Paschi as shares slump 20% investment picks
2014/10/27
SHANGHAI , Oct.
Sign-up for SMIC and ASML Sign a Volume Purchase Agreement Worth 450 Million Euros investment picks
FLORENCE, S.C. , Oct.
Sign-up for First Reliance Announces Strong 3rd Quarter Results investment picks
2014/10/27
--Top-line Results Confirming Safety, Liver Transfection Presented at ESGCT Conference--
Sign-up for AIPGENE Consortium Presents 1 Year Follow-Up Clinical Data from Acute Intermittent Porphyria Phase I Clinical Trial Using AAV5-PBGD Gene Therapy Candidate investment picks
Pacific Rubiales provides exploration update: 39 wells drilled, 72% success rate achieved, new production added Canada NewsWire TORONTO , Oct.
Sign-up for Pacific Rubiales provides exploration update: 39 wells drilled, 72% success rate achieved, new production added investment picks
Conference Call Scheduled at 9am ET AZOUR, Israel , October 27, 2014 /PRNewswire/ -- Ituran Location and Control Ltd.
Sign-up for Ituran Location and Control Ltd. Schedules Third Quarter Results Release and Conference Call for Tuesday, November 18, 2014 investment picks
Integrated Device Technology, Inc. ( IDT ® ) (NASDAQ:IDTI) today introduced a new low-distortion, low-power radio frequency (RF) mixer, delivering RF technology that reduces distortion in LTE and TDD systems while minimizing power consumption.
Sign-up for New IDT Mixer Lowers Distortion, Cuts Power Consumption up to 30% investment picks
2014/10/27
DENVER , Oct.
Sign-up for Antero Resources Corporation Third Quarter 2014 Earnings Release and Call investment picks
EdR (NYSE:EDR), one of the nation’s largest developers, owners and managers of collegiate housing, today announced results for the quarter ended September 30, 2014.
Sign-up for EdR Announces Third Quarter 2014 Results investment picks
THIRD-QUARTER REVENUE UP 8.9%; NINE MONTHS UP 5.8% NINE-MONTHS INCOME FROM CONTINUING OPERATIONS UP 11.7%; EPS $0.61 NINE-MONTHS ADJUSTED EPS $0.64 EXCLUDING SHARE COUNT IMPACT OF CONVERTIBLE NOTES CLEVELAND , Oct.
Sign-up for CBIZ Reports Third-Quarter And Nine-Months 2014 Results investment picks
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced positive top-line results from its Phase 2b placebo-controlled trial of AKB-6548 in non-dialysis patients with anemia related to chronic kidney disease (CKD). The study achieved its primary endpoint and AKB-6548 was generally well tolerated, confirming that the once-daily, oral therapy can successfully increase and maintain hemoglobin (HGB) levels.
Sign-up for Akebia Announces Positive Top-Line Results from its Phase 2b Study of AKB-6548 in Non-Dialysis Patients with Anemia Related to Chronic Kidney Disease investment picks
2014/10/27
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets erased earlier gains on Monday after data showed German business confidence has fallen to a 22-month low.
Sign-up for UPDATE: European stocks erase gains after weak German Ifo data investment picks
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch)--Among the companies whose shares are expected to see active trading in Monday's session are Twitter Inc., Merck & Co., and Allergan Inc. Twitter(TWTR) is projected to report third-quarter earnings of a penny a share, according to a consensus survey by FactSet.
Sign-up for UPDATE: Twitter, Merck, Allergan earnings in focus investment picks
2014/10/27
By Barbara Kollmeyer, MarketWatch MADRID (MarketWatch) -- U.S. stock futures struggling Monday as relief after European Union bank stress tests was replaced by worry over weak German data.
Sign-up for Stock futures flatten after weak German data; focus on Fed investment picks
2014/10/27
By Chuck Jaffe, MarketWatch The reaction of a lot of retirees last week to the news that their Social Security checks will rise next year by an average of $20 per month amounted to "Thanks for nothing." The question is whether they can turn that nothing into something.
Sign-up for UPDATE: How to make your $20-a-month COLA increase make a difference investment picks
2014/10/27
http://media.marketwire.com/attachments/201012/17558_MOENLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153952&ProfileId=051205&sourceType=1 NORTH OLMSTED, OH --
Sign-up for Moen Watch 2015 - Day 1: A Daily Look at Research Shaping 2015 Consumer Behavior Trends investment picks
Committed to Maintaining Corporate Governance Policies and Practices at Ashford Trust and Ashford Inc. that Best Serve Interests of Company and Shareholders DALLAS , Oct.
Sign-up for Ashford Trust Announces Corporate Governance Enhancements investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Sarepta Therapeutics Announces Regulatory Update on Eteplirsen to Ashford Trust Announces Corporate Governance Enhancements
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent